Trevi Therapeutics, INC. (TRVI) — DEF 14A Filings

All DEF 14A filings from Trevi Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Trevi Therapeutics Files DEF 14A on Executive Compensation — Apr 29, 2025 Risk: low
Trevi Therapeutics, Inc. filed its DEF 14A on April 29, 2025, detailing executive compensation and equity awards for the fiscal years ending December 31, 2023,
Trevi Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13 — Apr 26, 2024 Risk: low
Trevi Therapeutics, Inc. (TRVI) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting to be held virtually on June 13, 2024, at 12:30

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX